These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 22581864

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer.
    Tramontano AC, Cipriano LE, Kong CY, Shepard JA, Lanuti M, Gazelle GS, McMahon PM.
    AJR Am J Roentgenol; 2013 May; 200(5):1020-7. PubMed ID: 23617484
    [Abstract] [Full Text] [Related]

  • 8. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.
    Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S.
    Lancet Oncol; 2012 Aug; 13(8):802-9. PubMed ID: 22727222
    [Abstract] [Full Text] [Related]

  • 9. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.
    Sun B, Brooks ED, Komaki RU, Liao Z, Jeter MD, McAleer MF, Allen PK, Balter PA, Welsh JD, O'Reilly MS, Gomez D, Hahn SM, Roth JA, Mehran RJ, Heymach JV, Chang JY.
    Cancer; 2017 Aug 15; 123(16):3031-3039. PubMed ID: 28346656
    [Abstract] [Full Text] [Related]

  • 10. Treatment-Related Toxicity in Patients With Early-Stage Non-Small Cell Lung Cancer and Coexisting Interstitial Lung Disease: A Systematic Review.
    Chen H, Senan S, Nossent EJ, Boldt RG, Warner A, Palma DA, Louie AV.
    Int J Radiat Oncol Biol Phys; 2017 Jul 01; 98(3):622-631. PubMed ID: 28581404
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer.
    Dupuy DE, DiPetrillo T, Gandhi S, Ready N, Ng T, Donat W, Mayo-Smith WW.
    Chest; 2006 Mar 01; 129(3):738-45. PubMed ID: 16537876
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stereotactic ablative body radiotherapy (SABR): an alternative to surgery in stage I-II non-small-cell cancer of the lung?
    Mirimanoff RO.
    Chin Clin Oncol; 2015 Dec 01; 4(4):42. PubMed ID: 26730754
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer.
    Sher DJ, Wee JO, Punglia RS.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):e767-74. PubMed ID: 21300476
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis.
    Bi N, Shedden K, Zheng X, Kong FS.
    Int J Radiat Oncol Biol Phys; 2016 Aug 01; 95(5):1378-1390. PubMed ID: 27479723
    [Abstract] [Full Text] [Related]

  • 20. Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC.
    van den Berg LL, Klinkenberg TJ, Groen HJM, Widder J.
    J Thorac Oncol; 2015 May 01; 10(5):826-831. PubMed ID: 25629639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.